FDA Approves Cholesterol Drug From Regeneron, Sanofi

Federal regulators approved the first of a new class of cholesterol-lowering medicines, developed by Regeneron and Sanofi. The drug, called Praluent, provides a new option for high-risk heart patients.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Regeneron [+]    Sanofi [+]    Praluent [+]   

More #news: